| known also as: |
BMF, Bcl-2 Modifying Factor, FLJ00065), Anti-Bcl 2 Modifying Factor (Bcl2 Modifying Factor |
| known also as: |
BMF, Bcl-2 Modifying Factor, FLJ00065), Bcl 2 Modifying Factor (Bcl2 Modifying Factor |
| known also as: |
BMF, Bcl-2 Modifying Factor, FLJ00065), Bcl 2 Modifying Factor (Bcl2 Modifying Factor |
| known also as: |
Bcl 2 Modifying Factor |
| known also as: |
BMF, Bcl-2 Modifying Factor, FLJ00065), Anti -Bcl 2 Modifying Factor (Bcl2 Modifying Factor |
| Other names: |
Bcl-2-modifying factor, Bcl2 modifying factor, N/A, OTTHUMP00000160316, bcl-2-modifying factor, bcl-2-modifying factor isoform bmf-1 |
| Other gene names: |
BMF, FLJ00065, N/A, BMF |
| Category: |
Antibodies |
| Clonality: |
Polyclonal |
| Immunoglobulin isotype: |
IgG |
| Clone: |
Polyclonal antibody |
| Host organism: |
Source: Human, Host: Rabbit |
| Species reactivity: |
Human |
| Specificity and cross-reactivity: |
Recognizes human BMF |
| Purification method: |
Affinity Purified by immunoaffinity chromatography |
| Form/Appearance: |
0, 02% sodium azide, Supplied as a liquid in PBS |
| Storage and shipping: |
Aliquots are stable for at least 12 months productone should be stored at -20 degrees Celsius, For long-term storage and to avoid repeated freezing and thawing, For maximum recovery of product, Further dilutions can be made in assay buffer, add sterile 40-50% glycerol, aliquot and For optimal long term storage, centrifuge the original vial after thawing and prior to removing the cap, productone should be kept at -20 degrees Celsius, Store at 4 degrees Celsius for short term storage |
| Tested for:: |
Immunohistochemistry (IHC), Western Blot (WB) |
| Description: |
Polyclonal antibodies generally are more stable and retain their reactivity under unfavorable conditions, Polyclonal antibodies have series of advantages - larger batches can be supplied at a time, Properly used, To obtain more detailed information on productone, please, refer to the full product datasheet, the time needed for production is considerably shorter, they are inexpensive to manufacture and respectively to buy, this antibody will ensure excellent and reproducible results with guaranteed success for the applications that it is tested in, productone is a polyclonal antibody of high purity and binding affinity for the antigen that it is risen against |
| Advisory: |
For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, avoid cycles of freezing and thawing, please, In order to retain the quality and the affinity of productone unchanged |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by MBS Polyclonals_1 they should be stored frozen at - 24° |
| Gene target: |
BMF, Bcl-2 Modifying Factor, FLJ00065), Bcl 2 Modifying Factor (Bcl2 Modifying Factor |
| Short name: |
BMF, Bcl-2 Modifying Factor, FLJ00065) Antibody, Bcl 2 Modifying Factor (Bcl2 Modifying Factor |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
Bcl-2 Modifying Factor, Bcl2 modifying factor, FLJ00065) (Antibody to), Bcl 2 Modifying Factor (B-cell CLL/lymphoma 2 Modifying Factor |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
BMF and IDBG-6070 and ENSG00000104081 and 90427, BMF and IDBG-646206 and ENSBTAG00000012180 and 541141, Bmf and IDBG-198160 and ENSMUSG00000040093 and 171543, Plasma membranes, protein binding, this GO :0001669 and acrosomal vesicle and cellular component this GO :0005515 and protein binding and molecular function this GO :0005737 and cytoplasm and cellular component this GO :0005741 and mitochondrial outer membrane and cellular component this GO :0005829 and cytosol and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0006915 and apoptotic process and biological process this GO :0015629 and actin cytoskeleton and cellular component this GO :0016459 and myosin complex and cellular component this GO :0032464 and positive regulation of protein homooli this GO merization and biological process this GO :0043276 and anoikis and biological process this GO :0090200 and positive regulation of release of cytochrome c from mitochondria and biological process this GO :0097193 and intrinsic apoptotic signaling pathway and biological process this GO :1900740 and positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway and biological process this GO :2001234 and negative regulation of apoptotic signaling pathway and biological process this GO :2001235 and positive regulation of apoptotic signaling pathway and biological process this GO :2001244 and positive regulation of intrinsic apoptotic signaling pathway and biological process, this GO :0005515 : protein binding, this GO :0005515 : protein binding, Bcl2 modifying factor |
| Identity: |
24132 |
| Gene: |
BMF |
More about : BMF |
| Long gene name: |
Bcl2 modifying factor |
| Synonyms: |
FLJ00065 |
| Locus: |
15q15, 1 |
| Discovery year: |
2004-01-16 |
| GenBank acession: |
BC060783 |
| Entrez gene record: |
90427 |
| Pubmed identfication: |
11546872 |
| RefSeq identity: |
NM_033503 |
| Classification: |
BCL2 homology region 3 (BH3) only |
| Havana BLAST/BLAT: |
OTTHUMG00000129875 |